Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (131-140 of 250) with videos related to

Pageof 25
Sort By:
Parkinsonism & Related Disorders|August 12, 2009
Costs of Parkinson's disease in eastern Europe: a Czech cohort studyYaroslav Winter, Sonja von Campenhausen, Hana Brozova, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 9, 2014
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational StudyCatherine Reed, Mark Belger, Grazia Dell'agnello, et al.
Health and Quality of Life Outcomes|January 23, 2017
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?Catherine Reed, Annabel Barrett, Jeremie Lebrec, et al.
Pharmacopsychiatry|February 2, 2018
Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's DiseasePhilipp Hessmann, Richard Dodel, Erika Baum, et al.
International Clinical Psychopharmacology|November 8, 2017
Use of antidementia drugs in German patients with Alzheimer's diseasePhilipp Hessmann, Richard Dodel, Erika Baum, et al.
Journal of Alzheimer'S Disease : JAD|October 31, 2017
Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to DementiaRon L H Handels, Anders Wimo, Richard Dodel, et al.
International Journal of Psychiatry in Clinical Practice|December 14, 2017
Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in GermanyPhilipp Hessmann, Richard Dodel, Erika Baum, et al.
Journal of Autoimmunity|March 4, 2025
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicityCarmen Noelker, Florian Seitz, Annekathrin Sturn, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementiaMark Belger, Josep Maria Haro, Catherine Reed, et al.
Pharmacoeconomics|August 12, 2009
Costs of illness in a Russian cohort of patients with Parkinson's diseaseYaroslav Winter, Sonja von Campenhausen, Georgy Popov, et al.
Pageof 25

Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
Parkinsonism & Related Disorders|August 12, 2009
Costs of Parkinson's disease in eastern Europe: a Czech cohort studyYaroslav Winter, Sonja von Campenhausen, Hana Brozova, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 9, 2014
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational StudyCatherine Reed, Mark Belger, Grazia Dell'agnello, et al.
Health and Quality of Life Outcomes|January 23, 2017
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?Catherine Reed, Annabel Barrett, Jeremie Lebrec, et al.
Pharmacopsychiatry|February 2, 2018
Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's DiseasePhilipp Hessmann, Richard Dodel, Erika Baum, et al.
International Clinical Psychopharmacology|November 8, 2017
Use of antidementia drugs in German patients with Alzheimer's diseasePhilipp Hessmann, Richard Dodel, Erika Baum, et al.
Journal of Alzheimer'S Disease : JAD|October 31, 2017
Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to DementiaRon L H Handels, Anders Wimo, Richard Dodel, et al.
International Journal of Psychiatry in Clinical Practice|December 14, 2017
Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in GermanyPhilipp Hessmann, Richard Dodel, Erika Baum, et al.
Journal of Autoimmunity|March 4, 2025
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicityCarmen Noelker, Florian Seitz, Annekathrin Sturn, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementiaMark Belger, Josep Maria Haro, Catherine Reed, et al.
Pharmacoeconomics|August 12, 2009
Costs of illness in a Russian cohort of patients with Parkinson's diseaseYaroslav Winter, Sonja von Campenhausen, Georgy Popov, et al.
Pageof 25